Improvements in the treatment of congenital heart disease areamong the most impressive medical achievements of the secondhalf of the 20th century. In 1950, patent ductus arteriosusand aortic coarctation were the only correctable lesions, andthe likelihood that an infant who received a diagnosis of heartdisease in the 1960s would survive the first year of life wasonly 60 percent, whether treated medically or surgically.1 Between1979 and 1997, infant mortality from heart disease declinedby 39 percent,2 and survival rates continue to improve. In manycenters, one-year survival rates for infants undergoing heartsurgery now exceed . . . [Full Text of this Article]
Source Information
From the Department of Pediatrics, Vanderbilt University School of Medicine, Nashville (A.S.); and the Department of Cardiology, Children's Hospital, Harvard Medical School, Boston (J.E.L.).
This article has been cited by other articles:
Cox, G. F., Sleeper, L. A., Lowe, A. M., Towbin, J. A., Colan, S. D., Orav, E. J., Lurie, P. R., Messere, J. E., Wilkinson, J. D., Lipshultz, S. E.
(2006). Factors Associated With Establishing a Causal Diagnosis for Children With Cardiomyopathy. Pediatrics
118: 1519-1531
[Abstract][Full Text]
Bond, J, Flintoff, K, Higgins, J, Scott, S, Bennet, C, Parsons, J, Mannon, J, Jafri, H, Rashid, Y, Barrow, M, Trembath, R, Woodruff, G, Rossa, E, Lynch, S, Sheilds, J, Newbury-Ecob, R, Falconer, A, Holland, P, Cockburn, D, Karbani, G, Malik, S, Ahmed, M, Roberts, E, Taylor, G, Woods, C G
(2005). The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J. Med. Genet.
42: e10-e10
[Full Text]
(2003). Learning More About Pediatric Cardiomyopathy. Journal Watch Cardiology
2003: 5-5
[Full Text]
Previous
